8Z3K image
Deposition Date 2024-04-15
Release Date 2024-12-11
Last Version Date 2025-03-05
Entry Detail
PDB ID:
8Z3K
Keywords:
Title:
The structure of type III CRISPR-associated deaminase in complex 2cA6-2ATP
Biological Source:
Source Organism:
Host Organism:
Method Details:
Experimental Method:
Resolution:
3.19 Å
Aggregation State:
PARTICLE
Reconstruction Method:
SINGLE PARTICLE
Macromolecular Entities
Polymer Type:polypeptide(L)
Molecule:Adenosine deaminase domain-containing protein
Gene (Uniprot):G4L39_03315
Chain IDs:A, B, C, D, E, F
Chain Length:635
Number of Molecules:6
Biological Source:Limisphaera ngatamarikiensis
Polymer Type:polyribonucleotide
Molecule:RNA (5'-R(P*AP*AP*AP*AP*AP*A)-3')
Chain IDs:G (auth: H), H (auth: I)
Chain Length:6
Number of Molecules:2
Biological Source:Limisphaera ngatamarikiensis
Primary Citation
Antiviral signaling of a type III CRISPR-associated deaminase.
Science 387 eadr0393 eadr0393 (2025)
PMID: 39666823 DOI: 10.1126/science.adr0393

Abstact

Prokaryotes have evolved diverse defense strategies against viral infection, such as foreign nucleic acid degradation by CRISPR-Cas systems and DNA/RNA synthesis inhibition via nucleotide pool depletion. Here, we report an antiviral mechanism of type III CRISPR-Cas-regulated ATP depletion, where ATP is converted into ITP by CRISPR-Cas-associated adenosine deaminase (CAAD) upon activation by either cA4 or cA6, followed by hydrolysis into IMP by Nudix hydrolase, ultimately resulting in cell growth arrest. The cryo-electron microscopy structures of CAAD in its apo and activated forms, together with biochemical evidence, revealed how cA4/cA6 binds to the CARF domain and abrogates CAAD autoinhibition, inducing substantial conformational changes that reshape the structure of CAAD and induce its deaminase activity. Our results reveal the mechanism of a CRISPR-Cas-regulated ATP depletion antiviral strategy.

Legend

Protein

Chemical

Disease

Primary Citation of related structures